POLITICAL ECONOMY OF THE PHARMACEUTICAL INDUSTRY.
Author | : |
Publisher | : |
Total Pages | : 116 |
Release | : 1984 |
ISBN-10 | : OCLC:932977195 |
ISBN-13 | : |
Rating | : 4/5 (95 Downloads) |
Read and Download All BOOK in PDF
Download Political Economy Of The Pharmaceutical Industry full books in PDF, epub, and Kindle. Read online free Political Economy Of The Pharmaceutical Industry ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads.
Author | : |
Publisher | : |
Total Pages | : 116 |
Release | : 1984 |
ISBN-10 | : OCLC:932977195 |
ISBN-13 | : |
Rating | : 4/5 (95 Downloads) |
Author | : Hans Löfgren |
Publisher | : Springer |
Total Pages | : 247 |
Release | : 2016-04-30 |
ISBN-10 | : 9781137315854 |
ISBN-13 | : 1137315857 |
Rating | : 4/5 (54 Downloads) |
Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs.
Author | : Jill A. Fisher |
Publisher | : Rutgers University Press |
Total Pages | : 273 |
Release | : 2008-11-06 |
ISBN-10 | : 9780813545936 |
ISBN-13 | : 0813545935 |
Rating | : 4/5 (36 Downloads) |
Today, more than 75 percent of pharmaceutical drug trials in the United States are being conducted in the private sector. Once the sole province of academic researchers, these important studies are now being outsourced to non-academic physicians. According to Jill A. Fisher, this major change in the way medical research is performed is the outcome of two problems in U.S. health care: decreasing revenue for physicians and decreasing access to treatment for patients. As physicians report diminishing income due to restrictive relationships with insurers, increasing malpractice insurance premiums, and inflated overhead costs to operate private practices, they are attracted to pharmaceutical contract research for its lucrative return. Clinical trials also provide limited medical access to individuals who have no or inadequate health insurance because they offer "free" doctors' visits, diagnostic tests, and medications to participants. Focusing on the professional roles of those involved, as well as key research practices, Fisher assesses the risks and advantages for physicians and patients alike when pharmaceutical drug studies are used as an alternative to standard medical care. A volume in the Critical Issues in Health and Medicine series, edited by Rima D. Apple and Janet Golden
Author | : Hans Löfgren |
Publisher | : Taylor & Francis |
Total Pages | : 370 |
Release | : 2017-07-06 |
ISBN-10 | : 9781351470605 |
ISBN-13 | : 1351470604 |
Rating | : 4/5 (05 Downloads) |
Some papers presented at a conference held at Hyderabad in September 2010.
Author | : Sherry S. Marcellin |
Publisher | : Routledge |
Total Pages | : 227 |
Release | : 2016-02-24 |
ISBN-10 | : 9781317020806 |
ISBN-13 | : 1317020804 |
Rating | : 4/5 (06 Downloads) |
This book provides a fresh, multidisciplinary, and exciting look at the making and remaking of pharmaceutical patents at the GATT/WTO, by utilising a Coxian political economy of continuity and change in the global political economy (GPE). Marcellin focuses on the role of the transnational drug industry in the making of the patent provisions in the original TRIPS Agreement and consequently, the role of the African Group at the WTO in the remaking of those patent provisions.
Author | : John B. McKinlay |
Publisher | : Routledge |
Total Pages | : 236 |
Release | : 2022-05-24 |
ISBN-10 | : 9781000578911 |
ISBN-13 | : 1000578917 |
Rating | : 4/5 (11 Downloads) |
Originally published in 1984, this book attempted to fill a gap by providing a broad-ranging structural analysis of the health care sector and the political and economic forces which influence its shape and contents, both in the western world and developing countries. The contributors examine the relationships of capitalism to health care, in terms of its influence on the physical environment, the incidence of social diseases and the prevailing (20th Century) view of what constitutes health itself; and in terms of the consequences of the new medical industrial complex it has created, such as the declining provision of health care for the poor and disadvantaged and the growing power of the pharmaceutical industry.
Author | : Kenneth C. Shadlen |
Publisher | : Oxford University Press |
Total Pages | : 263 |
Release | : 2017-08-04 |
ISBN-10 | : 9780192534842 |
ISBN-13 | : 019253484X |
Rating | : 4/5 (42 Downloads) |
Coalitions and Compliance examines how international changes can reconfigure domestic politics. Since the late 1980s, developing countries have been subject to intense pressures regarding intellectual property rights. These pressures have been exceptionally controversial in the area of pharmaceuticals. Historically, fearing the economic and social costs of providing private property rights over knowledge, developing countries did not allow drugs to be patented. Now they must do so, an obligation with significant implications for industrial development and public health. This book analyses different forms of compliance with this new imperative in Latin America, comparing the politics of pharmaceutical patenting in Argentina, Brazil, and Mexico. Coalitions and Compliance focuses on two periods of patent politics: initial conflicts over how to introduce drug patents, and then subsequent conflicts over how these new patent systems function. In contrast to explanations of national policy choice based on external pressures, domestic institutions, or Presidents' ideological orientations, this book attributes cross-national and longitudinal variation to the ways that changing social structures constrain or enable political leaders' strategies to construct and sustain supportive coalitions. The analysis begins with assessment of the relative resources and capabilities of the transnational and national pharmaceutical sectors, and these rival actors' efforts to attract allies. Emphasis is placed on two ways that social structures are transformed so as to affect coalition-building possibilities: how exporters fearing the loss of preferential market access may be converted into allies of transnational drug firms, and differential patterns of adjustment among state and societal actors that are inspired by the introduction of new policies. It is within the changing structural conditions produced by these two processes that political leaders build coalitions in support of different forms of compliance.
Author | : Maureen Mackintosh |
Publisher | : |
Total Pages | : 334 |
Release | : 2016 |
ISBN-10 | : 134956544X |
ISBN-13 | : 9781349565443 |
Rating | : 4/5 (4X Downloads) |
This book is open access under a CC-BY license. This book is about medicines production in sub-Saharan Africa, an enquiry driven by the vast unmet health needs of the sub-continent. It is a collective endeavour by a group of editors and authors with a strong African and more broadly Southern presence to find ways forward that link technological development, investment and industrial growth in pharmaceuticals to improve access to essential good quality medicines, as part of moving towards universal access to competent health care. We aim to shift the emphasis in international debate to give much more attention to the scope for sustained Africa-based and African-led initiatives to tackle this huge challenge. Without the technological, industrial, intellectual, organisational and research-related capabilities associated with competent pharmaceutical production, and without policies that pull the industrial sectors towards serving local health needs, the African sub-continent cannot generate the resources to tackle the needs and demands of its population.
Author | : Meir Perez Pugatch |
Publisher | : Edward Elgar Publishing |
Total Pages | : 298 |
Release | : 2004-01-01 |
ISBN-10 | : 1845420748 |
ISBN-13 | : 9781845420741 |
Rating | : 4/5 (48 Downloads) |
'This book is a substantial contribution to the discussion on trade-related intellectual property rights. It provides a clear, step-by-step, in-depth analysis of the TRIPS agreement, particularly as it relates to the European pharmaceutical industry. Politics, law and economics are judiciously blended. Meir Pugatch's work should be read not just by academic experts and students in the field, but also by trade policy and IPR practitioners interested in an accessible, policy-relevant treatment of the issues at hand.' - Razeen Sally, London School of Economics and Political Science, UK This book investigates the realm of intellectual property rights (IPRs) within the context of international political economy. In particular, it examines the extent to which powerful interest groups, such as pharmaceutical multinational companies, influence the political dynamism underlying the field of IPRs. Meir Perez Pugatch argues that a pure economic approach does not provide a sufficient or satisfactory explanation for the creation of intellectual property rights, most notably patents. The author instead suggests that a dynamic approach, based on the international political economy of interest groups and systemic outcomes, provides a better starting point for explaining how the international intellectual property agenda is determined.
Author | : Institute of Medicine |
Publisher | : National Academies Press |
Total Pages | : 225 |
Release | : 1991-02-01 |
ISBN-10 | : 9780309044912 |
ISBN-13 | : 030904491X |
Rating | : 4/5 (12 Downloads) |
Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.